newsfilter
← Latest News
GlobeNewswire·

Histogen to Report First Quarter 2022 Financial Results and Provide Business Update

SAN DIEGO, April 28, 2022 (GLOBE NEWSWIRE) -- Histogen Inc. (NASDAQ:HSTO), a clinical-stage therapeutics company focused on developing both restorative therapeutics and pan-caspase and caspase selective inhibitors focused on treatments for infectious a